PRE-SCREENINGDEVICE FOR SLEEP APNEA
Sector: Broadband • Location: Finland
Source: EU Funding & Tenders Portal
Obstructive sleep apnea (OSA) is a common disease, affecting 2–7% of population, but many of them are still undiagnosed. Nukute has developed a novel and cost effective technology to pre-screen and assist in treatment of OSA patients. Innovation utilizes noise (respiratory rate and profile) and acceleration of chest and diaphragm (respiratory motion) first time as biomarkers of OSA. In the pre-scr
- Status
- Closed
- Sector
- Broadband, Telecommunications
- Location
- Finland
- Updated
- 22 Jul 2026
- Source
- EU Funding & Tenders Portal
ConstructChat
Ask ConstructChat about PRE-SCREENINGDEVICE FOR SLEEP APNEA
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
| Not available for this record. |
Status
Original status | ended |
Taiyo status | Closed |
Taiyo last update | 2026-07-22 |
Contact
| Not available for this record. |
Description
Description | Obstructive sleep apnea (OSA) is a common disease, affecting 2–7% of population, but many of them are still undiagnosed. Nukute has developed a novel and cost effective technology to pre-screen and assist in treatment of OSA patients. Innovation utilizes noise (respiratory rate and profile) and acceleration of chest and diaphragm (respiratory motion) first time as biomarkers of OSA. In the pre-screening device a stereo microphone measures the ambient and respiratory sounds, and an accelerometer measures the motion of neck muscles. In addition to these components, the diagnostic device has also two more accelerators and a blood oxygen level measurement. In both cases, the data is wirelessly sent to the mobile phone application. If the device includes the treatment feature, an electrical stimulation prompts the user to adjust sleeping position for increased airflow, when apnea occurs. The first prototype of the device achieved a proof of the concept in the preclinical tests in the beginning of 2015 and the results were very good. The main benefits of this system compared to existing pre-screening and diagnostic devices are easiness to use, cheapness (70-90% cheaper than competitors), accuracy and comfort wireless design. The device has two main product lines: OSA diagnostic and treatment assistance device for professional use and OSA pre-screening and treatment assistance device for consumers. In a first stage, the target market of diagnostic device is Finnish hospitals and that of pre-screening device is consumers in the US. The device has potential to generate big societal savings in Europe and worldwide by offering cost-effective and easy way to pre-screen OSA. The main activities of this project are: creation of patent family in the US, creation of quality management system and application of CE marking, and preparation of US market entry combined with business plan updating. |
Location
Country | Finland |
Source
Source | EU Funding & Tenders Portal |
URL |
More Details
Record type | Project |
Sector | Broadband, Telecommunications |
Article published date | 2026-01-15 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project
